For: | Liu A, Perumpail RB, Kumari R, Younossi ZM, Wong RJ, Ahmed A. Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World J Hepatol 2015; 7(29): 2871-2879 [PMID: 26692331 DOI: 10.4254/wjh.v7.i29.2871] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v7/i29/2871.htm |
Number | Citing Articles |
1 |
Amna Younas, Junaid Riaz, Tamoor Chughtai, Hamza Maqsood, Muhammad Saim, Shaheryar Qazi, Shifa Younus, Umar Ghaffar, Muhammad Khaliq. Hyponatremia and Its Correlation With Hepatic Encephalopathy and Severity of Liver Disease. Cureus 2021; doi: 10.7759/cureus.13175
|
2 |
Wendy J. Dahl, Nicole C. Agro, Åsa M. Eliasson, Kaley L. Mialki, Joseph D. Olivera, Carley T. Rusch, Carly N. Young. Health Benefits of Fiber Fermentation. Journal of the American College of Nutrition 2017; 36(2): 127 doi: 10.1080/07315724.2016.1188737
|
3 |
Abdel-Naser Elzouki, Shireen Suliman, Rania Alhasan, Ali Abdullah, Muftah Othman, Ahmad Badi. Predicting mortality of patients with cirrhosis admitted to medical intensive care unit: An experience of a single tertiary center. Arab Journal of Gastroenterology 2016; 17(4): 159 doi: 10.1016/j.ajg.2016.11.003
|
4 |
Yan Zhang, Da-Feng Mao, Mei-Wu Zhang, Xiao-Xiang Fan. Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension. World Journal of Gastroenterology 2017; 23(45): 8044-8052 doi: 10.3748/wjg.v23.i45.8044
|
5 |
Amir Abbasnezhad, Razieh Choghakhori, Sara Kashkooli, Meysam Alipour, Omid Asbaghi, Rasool Mohammadi. Effect of L‐carnitine on liver enzymes and biochemical factors in hepatic encephalopathy: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2019; 34(12): 2062 doi: 10.1111/jgh.14765
|
6 |
Mark Hudson, Marcus Schuchmann. Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. European Journal of Gastroenterology & Hepatology 2019; 31(4): 434 doi: 10.1097/MEG.0000000000001311
|
7 |
Mai Abdel Moneim, Doaa H. Abdelaziz, Yosra Ibrahim Nagy, Amin Abdel Baki, Ahmed S. Attia, Nirmeen Sabry. Rifaximin microbial resistance and its efficacy and safety as a secondary prophylaxis of hepatic encephalopathy in patients with hepatitis C virus‐related cirrhosis. International Journal of Clinical Practice 2021; 75(11) doi: 10.1111/ijcp.14807
|
8 |
G. F. Cittolin-Santos, A. M. de Assis, P. A. Guazzelli, L. G. Paniz, J. S. da Silva, M. E. Calcagnotto, G. Hansel, K. C. Zenki, E. Kalinine, M. M. Duarte, D. O. Souza. Guanosine Exerts Neuroprotective Effect in an Experimental Model of Acute Ammonia Intoxication. Molecular Neurobiology 2017; 54(5): 3137 doi: 10.1007/s12035-016-9892-4
|
9 |
Alexandros O. Konstantinidis, Katerina K. Adamama-Moraitou, Michail N. Patsikas, Lysimachos G. Papazoglou. Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis. Veterinary Sciences 2023; 10(5): 346 doi: 10.3390/vetsci10050346
|
10 |
Victoria Jaeger, Sharon DeMorrow, Matthew McMillin. The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy. Journal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2019.00025
|
11 |
Gianni Biancofiore. Practical Trends in Anesthesia and Intensive Care 2017. 2018; : 121 doi: 10.1007/978-3-319-61325-3_8
|
12 |
Kazuto TAJIRI, Yuka FUTSUKAICHI, Saito KOBAYASHI, Satoshi YASUMURA, Terumi TAKAHARA, Masami MINEMURA, Toshiro SUGIYAMA. L-Carnitine for the Treatment of Overt Hepatic Encephalopathy in Patients with Advanced Liver Cirrhosis. Journal of Nutritional Science and Vitaminology 2018; 64(5): 321 doi: 10.3177/jnsv.64.321
|
13 |
P. Muriel, E. Fernández-Martínez, S. Montes. Liver Pathophysiology. 2017; : 427 doi: 10.1016/B978-0-12-804274-8.00033-3
|
14 |
Ching Chang, Chien-Hao Huang, Hsiao-Jung Tseng, Fang-Chen Yang, Rong-Nan Chien. Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in Taiwan. Journal of Personalized Medicine 2021; 11(6): 478 doi: 10.3390/jpm11060478
|